← 返回

结合单细胞和批量 RNA 测序,NK 细胞标记基因揭示胰腺导管腺癌的预后和免疫状态

英文原题:Combining single-cell and bulk RNA sequencing, NK cell marker genes reveal a prognostic and immune status in pancreatic ductal adenocarcinoma.

查看英文原题

Combining single-cell and bulk RNA sequencing, NK cell marker genes reveal a prognostic and immune status in pancreatic ductal adenocarcinoma.

PubMed 2024/07/01(内容时间) Sci Rep Q1 · IF 4.9(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

NK细胞是胰腺导管腺癌(PDAC)肿瘤微环境的重要组成部分,在PDAC的发生发展中也发挥重要作用。本研究旨在探讨NK细胞标记基因与PDAC患者预后及免疫应答之间的关系。通过scRNA-seq数据,我们发现PDAC中NK细胞比例显著下调,并筛选出373个NK细胞标记基因。通过TCGA数据库,我们纳入7个NK细胞标记基因构建了预测PDAC患者预后的特征模型。Cox分析确定该特征模型为胰腺癌的独立因素。随后,该特征模型的预测能力通过6个GEO数据集得到验证,并具有良好的评价效果。我们对特征模型与患者免疫状态关系的分析显示,该特征模型与免疫细胞浸润、炎症反应、免疫检查点抑制剂(ICIs)应答具有很强的相关性。NK细胞标记基因与PDAC患者的预后和免疫能力密切相关,具有作为治疗靶点的潜在价值。

展开英文摘要原文

The NK cell is an important component of the tumor microenvironment of pancreatic ductal adenocarcinoma (PDAC), also plays a significant role in PDAC development.

This study aimed to explore the relationship between NK cell marker genes and prognosis, immune response of PDAC patients. By scRNA-seq data, we found the proportion of NK cells were significantly downregulated in PDAC and 373 NK cell marker genes were screened out.

By TCGA database, we enrolled 7 NK cell marker genes to construct the signature for predicting prognosis in PDAC patients. Cox analysis identified the signature as an independent factor for pancreatic cancer. Subsequently, the predictive power of signature was validated by 6 GEO datasets and had an excellent evaluation.

Our analysis of relationship between the signature and patients' immune status revealed that the signature has a strong correlation with immunocyte infiltration, inflammatory reaction, immune checkpoint inhibitors (ICIs) response. The NK cell marker genes are closely related to the prognosis and immune capacity of PDAC patients, and they have potential value as a therapeutic target.

论文信息

作者
Ouyang Y、Shen R、Chu L、Fu C、Hu W、Huang H、Zhang Z、Jiang M
第一作者单位
Research Institute of General Surgery, Jinling Hospital, Nanjing University Medical School, 305 Zhong Shan East Road, Nanjing, 210002, China. 854449245@qq.com.China
通讯作者单位
Research Institute of General Surgery, Jinling Hospital, Nanjing University Medical School, 305 Zhong Shan East Road, Nanjing, 210002, China. shenrongxi1@163.com.China
期刊
Scientific reports2024 Jul 1
原文标识
PubMed 38951569 · DOI 10.1038/s41598-024-65917-1